→ Regulatory Intelligence
services
Regulatory Intelligence
→ Formulation &
Market Access
From Regulatory Intelligence to Market-
Ready Formulations.
Effective regulatory strategy starts early in product development, as formulation choices can influence classification, data requirements, claims and market access. We help companies integrate regulatory intelligence into R&D from the outset, assessing formulation concepts, ingredients, co-formulants, substance status, restrictions and potential regulatory barriers across plant protection products, biocides, biostimulants, fertilising products, REACH and CLP. By combining formulation expertise with regulatory insight and monitoring evolving requirements, we help R&D teams anticipate constraints, optimise development programmes and avoid costly reformulations.
We bring regulatory considerations into formulation decisions early, helping companies develop compliant, viable products that are ready for future market requirements.
What We Deliver
- Regulatory intelligence and formulation strategy
- Regulatory feasibility assessments during product development
- Ingredient and co-formulant evaluations
- Classification and labelling impact assessments REACH and CLP compliance support
- Cross-regulatory assessments across multiple legislative frameworks
- Identification of substances of concern and endocrine disruptor risks
- Portfolio and innovation project support
- Support from concept development to commercialisation
Why It Matters
Bring regulatory
intelligence into R&D
from day one/
Early regulatory assessment helps companies identify compliance risks, anticipate restrictions linked to substances of concern and endocrine disruptors, assess the impact of potentially restrictive classifications and evaluate formulation options before development decisions become regulatory obstacles. The result: more robust, future-ready formulations, fewer compliance risks, lower reformulation costs and a clearer path to long-term market access.
